Advertisement News Archives - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

News

July 18, 2019

PureTech acquires new clinical-stage programme LYT-100 to treat lymphedema

PureTech Health, an advanced biopharmaceutical company developing novel medicines for dysfunctions of the Brain-Immune-Gut (BIG) axis, announced it has acquired and plans to develop a clinical-stage product candidate for the potential treatment of lymphatic and immunofibrotic diseases, including lymphedema.

PureTech acquires new clinical-stage programme LYT-100 to treat lymphedema